-
Something wrong with this record ?
Theranostic Approach for the Protein Corona of Polysaccharide Nanoparticles
S. Skalickova, P. Horky, V. Mlejnkova, J. Skladanka, B. Hosnedlova, B. Ruttkay-Nedecky, C. Fernandez, R. Kizek
Language English Country United States
Document type Journal Article, Review
Grant support
NANOCSDOXO 306/2018/FaF
LPR_273/2019
CA LTC18002
LPR_273/2019
PubMed
33274843
DOI
10.1002/tcr.202000042
Knihovny.cz E-resources
- MeSH
- Adjuvants, Immunologic therapeutic use MeSH
- Atherosclerosis diagnostic imaging MeSH
- Biomarkers analysis MeSH
- Immunity, Humoral drug effects MeSH
- Humans MeSH
- Neoplasms diagnostic imaging MeSH
- Nanoparticles chemistry therapeutic use MeSH
- Polysaccharides chemistry therapeutic use MeSH
- Protein Corona * immunology MeSH
- Theranostic Nanomedicine methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Polysaccharide nanoparticles are promising materials in the wide range of disciplines such as medicine, nutrition, food production, agriculture, material science and others. They excel not only in their non-toxicity and biodegradability but also in their easy preparation. As well as inorganic particles, a protein corona (PC) around polysaccharide nanoparticles is formed in biofluids. Moreover, it has been considered that the overall response of the organism to nanoparticles presence depends on the PC. This review summarises scientific publications about the structural chemistry of polysaccharide nanoparticles and their impact on theranostic applications. Three strategies of implementation of the PC in theranostics have been discussed: I) Utilisation of the PC in therapy; II) How the composition of the PC is analysed for specific disease markers; III) How the formed PC can interact with the immune system and enhances the immunomodulation or immunoelimination. Thus, the findings from this review can contribute to improve the design of drug delivery systems. However, it is still necessary to elucidate the mechanisms of nano-bio interactions and discover new connections in nanoscale research.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026231
- 003
- CZ-PrNML
- 005
- 20211026133107.0
- 007
- ta
- 008
- 211013s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/tcr.202000042 $2 doi
- 035 __
- $a (PubMed)33274843
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Skalickova, Sylvie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho 1946/1, 612 00, Brno, Czech Republic $u Department of Animal Nutrition and Forage Production, Mendel University in Brno, Zemedelska 1, 613 00, Brno, Czech Republic
- 245 10
- $a Theranostic Approach for the Protein Corona of Polysaccharide Nanoparticles / $c S. Skalickova, P. Horky, V. Mlejnkova, J. Skladanka, B. Hosnedlova, B. Ruttkay-Nedecky, C. Fernandez, R. Kizek
- 520 9_
- $a Polysaccharide nanoparticles are promising materials in the wide range of disciplines such as medicine, nutrition, food production, agriculture, material science and others. They excel not only in their non-toxicity and biodegradability but also in their easy preparation. As well as inorganic particles, a protein corona (PC) around polysaccharide nanoparticles is formed in biofluids. Moreover, it has been considered that the overall response of the organism to nanoparticles presence depends on the PC. This review summarises scientific publications about the structural chemistry of polysaccharide nanoparticles and their impact on theranostic applications. Three strategies of implementation of the PC in theranostics have been discussed: I) Utilisation of the PC in therapy; II) How the composition of the PC is analysed for specific disease markers; III) How the formed PC can interact with the immune system and enhances the immunomodulation or immunoelimination. Thus, the findings from this review can contribute to improve the design of drug delivery systems. However, it is still necessary to elucidate the mechanisms of nano-bio interactions and discover new connections in nanoscale research.
- 650 _2
- $a adjuvancia imunologická $x terapeutické užití $7 D000276
- 650 _2
- $a ateroskleróza $x diagnostické zobrazování $7 D050197
- 650 _2
- $a biologické markery $x analýza $7 D015415
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a humorální imunita $x účinky léků $7 D056724
- 650 _2
- $a nanočástice $x chemie $x terapeutické užití $7 D053758
- 650 _2
- $a nádory $x diagnostické zobrazování $7 D009369
- 650 _2
- $a polysacharidy $x chemie $x terapeutické užití $7 D011134
- 650 12
- $a proteinová korona $x imunologie $7 D000066970
- 650 _2
- $a teranostická nanomedicína $x metody $7 D000068936
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Horky, Pavel $u Department of Animal Nutrition and Forage Production, Mendel University in Brno, Zemedelska 1, 613 00, Brno, Czech Republic
- 700 1_
- $a Mlejnkova, Veronika $u Department of Animal Nutrition and Forage Production, Mendel University in Brno, Zemedelska 1, 613 00, Brno, Czech Republic
- 700 1_
- $a Skladanka, Jiri $u Department of Animal Nutrition and Forage Production, Mendel University in Brno, Zemedelska 1, 613 00, Brno, Czech Republic
- 700 1_
- $a Hosnedlova, Bozena $u Department of Research and Development, Prevention Medicals, Tovarni 342, 742 13, Studenka-Butovice, Czech Republic $u Department of Viticulture and Enology, Faculty of Horticulture, Mendel University in Brno, Valticka 337, CZ-691 44, Lednice, Czech Republic
- 700 1_
- $a Ruttkay-Nedecky, Branislav $u Department of Research and Development, Prevention Medicals, Tovarni 342, 742 13, Studenka-Butovice, Czech Republic $u Department of Viticulture and Enology, Faculty of Horticulture, Mendel University in Brno, Valticka 337, CZ-691 44, Lednice, Czech Republic $u Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackeho 1946/1, 612 00, Brno, Czech Republic
- 700 1_
- $a Fernandez, Carlos $u School of Pharmacy and Life Sciences, Robert Gordon University, Garthdee Road, AB10 7QB, Aberdeen, UK
- 700 1_
- $a Kizek, Rene $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho 1946/1, 612 00, Brno, Czech Republic $u Department of Research and Development, Prevention Medicals, Tovarni 342, 742 13, Studenka-Butovice, Czech Republic $u Department of Viticulture and Enology, Faculty of Horticulture, Mendel University in Brno, Valticka 337, CZ-691 44, Lednice, Czech Republic $u Department of Biomedical and Environmental Analyses, Faculty of Pharmacy with Division of Laboratory Medicine, Wroclaw Medical University, Borowska 211, 50-556, Wroclaw, Poland
- 773 0_
- $w MED00208282 $t Chemical record (New York, N.Y.) $x 1528-0691 $g Roč. 21, č. 1 (2021), s. 17-28
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33274843 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133113 $b ABA008
- 999 __
- $a ok $b bmc $g 1715058 $s 1146738
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 21 $c 1 $d 17-28 $e 20201204 $i 1528-0691 $m Chemical record $n Chem Rec $x MED00208282
- GRA __
- $a NANOCSDOXO 306/2018/FaF $p LPR_273/2019
- GRA __
- $a CA LTC18002 $p LPR_273/2019
- LZP __
- $a Pubmed-20211013